Integrated BioPharma Management
Management criteria checks 3/4
Integrated BioPharma's CEO is Riva Sheppard, appointed in May 2019, has a tenure of 5.08 years. total yearly compensation is $306.04K, comprised of 79.1% salary and 20.9% bonuses, including company stock and options. directly owns 4.28% of the company’s shares, worth $287.69K. The average tenure of the management team and the board of directors is 5.1 years and 22.5 years respectively.
Key information
Riva Sheppard
Chief executive officer
US$306.0k
Total compensation
| CEO salary percentage | 79.1% |
| CEO tenure | 5.1yrs |
| CEO ownership | 4.3% |
| Management average tenure | 5.1yrs |
| Board average tenure | 22.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$116k |
| Dec 31 2023 | n/a | n/a | -US$385k |
| Sep 30 2023 | n/a | n/a | -US$58k |
| Jun 30 2023 | US$306k | US$242k | -US$34k |
| Mar 31 2023 | n/a | n/a | US$1m |
| Dec 31 2022 | n/a | n/a | US$2m |
| Sep 30 2022 | n/a | n/a | US$3m |
| Jun 30 2022 | US$278k | US$230k | US$4m |
| Mar 31 2022 | n/a | n/a | US$7m |
| Dec 31 2021 | n/a | n/a | US$7m |
| Sep 30 2021 | n/a | n/a | US$7m |
| Jun 30 2021 | US$245k | US$219k | US$8m |
| Mar 31 2021 | n/a | n/a | US$5m |
| Dec 31 2020 | n/a | n/a | US$5m |
| Sep 30 2020 | n/a | n/a | US$5m |
| Jun 30 2020 | US$226k | US$214k | US$4m |
| Mar 31 2020 | n/a | n/a | US$3m |
| Dec 31 2019 | n/a | n/a | US$3m |
| Sep 30 2019 | n/a | n/a | US$2m |
| Jun 30 2019 | US$202k | US$178k | US$2m |
| Mar 31 2019 | n/a | n/a | US$2m |
| Dec 31 2018 | n/a | n/a | US$2m |
| Sep 30 2018 | n/a | n/a | US$1m |
| Jun 30 2018 | US$183k | US$176k | US$679k |
| Mar 31 2018 | n/a | n/a | US$1m |
| Dec 31 2017 | n/a | n/a | US$1m |
| Sep 30 2017 | n/a | n/a | US$2m |
| Jun 30 2017 | US$181k | US$174k | US$2m |
Compensation vs Market: Riva's total compensation ($USD306.04K) is below average for companies of similar size in the US market ($USD680.27K).
Compensation vs Earnings: Riva's compensation has increased whilst the company is unprofitable.
CEO
Riva Sheppard (57 yo)
5.1yrs
Tenure
US$306,043
Compensation
Mrs. Riva Kay Sheppard has been Co-Chief Executive Officer of Integrated Biopharma Inc. since May 1, 2019. Mrs. Sheppard served as Executive Vice President at Integrated Biopharma Inc. (aka: Integrated Bio...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-CEO & Director | 5.1yrs | US$306.04k | 4.28% $ 287.7k | |
| Co-CEO & Director | 5.1yrs | US$301.32k | 4.23% $ 284.2k | |
| Senior VP | 18.6yrs | US$329.52k | 0.52% $ 34.9k | |
| Head of Investor Relations | no data | no data | no data |
5.1yrs
Average Tenure
57yo
Average Age
Experienced Management: INBP's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-CEO & Director | 33.1yrs | US$306.04k | 4.28% $ 287.7k | |
| Co-CEO & Director | 29.5yrs | US$301.32k | 4.23% $ 284.2k | |
| Independent Director | 3.6yrs | US$30.36k | 0% $ 0 | |
| Director | 2yrs | US$27.28k | 0.033% $ 2.2k | |
| Independent Director | 29.5yrs | US$30.78k | 0.20% $ 13.2k | |
| Director | 15.5yrs | US$30.28k | 0.29% $ 19.8k |
22.5yrs
Average Tenure
67yo
Average Age
Experienced Board: INBP's board of directors are seasoned and experienced ( 22.5 years average tenure).